WHO ICTRP trial
The respiratory depression of concomitant infusion of remimazolam and…
KCT0009178 · Clinical Research Information Service (CRIS) · Not Recruiting
Key facts
| Trial ID | KCT0009178 |
|---|---|
| Public title | The respiratory depression of concomitant infusion of remimazolam and remifentanil using targeting effect-site concentrations |
| Scientific title | The respiratory depression of concomitant infusion of remimazolam and remifentanil using targeting effect-site concentrations |
| Primary sponsor | Ajou University Hospital |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Not Recruiting |
| Study type | Interventional Study |
| Phase | Not applicable |
| Countries | Korea, Republic of |
| Conditions | Factors influencing health status and contact with health services |
| Interventions | Drug : While administering remimazolam with a target effect-site concentration maintaining a blood concentration of 500 ng/ml, the study aims to concurrently administer the narcotic analgesic remifentanil with target effect-site… |
| Registration date | Feb 16, 2024 |
| Target size | 108 |
| Registry page | cris.nih.go.kr |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: